Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Birth Defects Research. Part C, Embryo Today : Reviews|December 11, 2008
Engineered microenvironments for human stem cellsAmandine F G Godier, Darja Marolt, Sharon Gerecht, et al.
Tissue Engineering. Part A|August 15, 2009
Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor cultureMirjam Fröhlich, Warren L Grayson, Darja Marolt, et al.
Scientific Reports|July 20, 2018
Segmental Additive Tissue EngineeringMartina Sladkova, Rawan Alawadhi, Rawan Jaragh Alhaddad, et al.
Annals of the New York Academy of Sciences|February 5, 2011
Potential pathophysiological mechanisms in osteonecrosis of the jawRegina Landesberg, Victoria Woo, Serge Cremers, et al.
Stem Cell Reviews and Reports|March 23, 2020
Increased Exhaustion of the Subchondral Bone-Derived Mesenchymal Stem/ Stromal Cells in Primary Versus Dysplastic OsteoarthritisKlemen Čamernik, Anže Mihelič, Rene Mihalič, et al.
Stem Cell Research|May 28, 2019
Skeletal-muscle-derived mesenchymal stem/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cellsKlemen Čamernik, Anže Mihelič, Rene Mihalič, et al.
Tissue Engineering. Part A|August 22, 2018
Comparison of Decellularized Cow and Human Bone for Engineering Bone Grafts with Human Induced Pluripotent Stem CellsMartina Sladkova, Jiayi Cheng, Michael Palmer, et al.
Frontiers in Bioengineering and Biotechnology|August 21, 2023
Engineering of extracellular matrix from human iPSC-mesenchymal progenitors to enhance osteogenic capacity of human bone marrow stromal cells independent of their ageDominik Hanetseder, Tina Levstek, Andreas Herbert Teuschl-Woller, et al.
Pharmaceutics|December 30, 2020
Effect of Diphenyleneiodonium Chloride on Intracellular Reactive Oxygen Species Metabolism with Emphasis on NADPH Oxidase and Mitochondria in Two Therapeutically Relevant Human Cell TypesSergejs Zavadskis, Adelheid Weidinger, Dominik Hanetseder, et al.
Computational and Structural Biotechnology Journal|January 6, 2025
CTGCT, Centre of Excellence for the Technologies of Gene and Cell Therapy: Collaborative translation of scientific discoveries into advanced treatments for neurological rare genetic diseases and cancerDarja Marolt Presen, Duško Lainšček, Jane Kinghorn, et al.
Pageof 6